Communication and informed consent in phase 1 trials: a review of the literature
Phase 1 (P1) trials are vital to the development of cancer treatments; however, the patients involved in these trials are unlikely to receive any therapeutic benefit, and there are significant possibilities that they will experience serious side effects. Ethical requirements stipulate that patients must be adequately informed before they consent to participate in P1 trials. This review focuses on studies that have measured patient comprehension of information given during the informed consent process of P1 cancer trials. Patients consenting to participate in P1 trials currently have a limited understanding of trial purpose, an unrealistic expectation of the benefits and risks associated with trial participation and a questionable appreciation of their right to abstain or withdraw. Health care professionals recruiting to P1 trials need clear and practical guidelines and training packages designed to ensure that all details of P1 trials are communicated effectively to eligible patients.
KeywordsPhase 1 trials Informed consent Communication
We thank Cancer Research UK for funding the authors of this review.
- 1.World Health Organization (1995) Guidelines for good clinical practice (GCP) for trials on pharmaceutical products. World Health Organization, GenevaGoogle Scholar
- 8.Daugherty C, Kass N, Fogarty LA, Sugarman J, Hlubocky F (2003) A randomized trial of a CD-ROM educational intervention for advanced cancer patients (acp) enrolling in early phase trials. Proc Am Soc Clin Oncol 22:521Google Scholar
- 12.Pentz RD, Flamm AL, Sugarman J, Cohen MZ, Daniel Ayers G, Herbst RS, Abbruzzese JL (2002) Study of the media’s potential influence on prospective research participants’ understanding of and motivations for participation in a high-profile phase I trial. J Clin Oncol 20:3785–3791PubMedCrossRefGoogle Scholar
- 15.Aaronson N, Visser-Pol E, Leenhouts G, Muller M, van der Schot A, van Dam F, Keus R, Koning C, ten Bokkel Huinink W, van Dongen J, Dubbelman R (1996) Telephone-based nursing intervention improves the effectiveness of the informed consent process in cancer clinical trials. J Clin Oncol 14:984–996PubMedGoogle Scholar
- 20.Meropol NJ, Weinfurt KP, Burnett CB, Balshem A, Benson AB, 3rd, Castel L, Corbett S, Diefenbach M, Gaskin D, Li Y, Manne S, Marshall J, Rowland JH, Slater E, Sulmasy DP, Van Echo D, Washington S, Schulman KA (2003) Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication. J Clin Oncol 21:2589–2596PubMedCrossRefGoogle Scholar